The diagnostic and prognostic value of haematologic parameters in multiple myeloma patients

References

• Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–e548. doi:10.1016/S1470-2045(14)70442-5
   PubMed Web of Science ®Google Scholar
• Padala SA, Barsouk A, Barsouk A, et al. Epidemiology, staging, and management of multiple myeloma. Med Sci (Basel). 2021;9:3. doi:10.3390/medsci9010003.
   PubMedGoogle Scholar
• Allegra A, Innao V, Allegra AG, et al. Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma. Int J Mol Sci. 2019;20:2822. doi:10.3390/ijms20112822.
   PubMed Web of Science ®Google Scholar
• Ege H, Gertz MA, Markovic SN, et al. Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol. 2008;141:792–798. doi:10.1111/j.1365-2141.2008.07123.x
   PubMed Web of Science ®Google Scholar
• Jovanović KK, Escure G, Demonchy J, et al. Deregulation and targeting of TP53 pathway in multiple myeloma. Front Oncol. 2018;8:665. doi:10.3389/fonc.2018.00665.
   PubMed Web of Science ®Google Scholar
• Garrido D, Slavutsky I, Riva E. Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting. Curr Probl Cancer. 2023;47:100916). doi:101016/j.
   PubMed Web of Science ®Google Scholar
• Koundouros N, Poulogiannis G. Reprogramming of fatty acid metabolism in cancer. Br J Cancer. 2020;122:4–22. doi:10.1038/s41416-019-0650-z
   PubMed Web of Science ®Google Scholar
• Liu Q, Luo Q, Halim A, et al. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the warburg effect by cetuximab. Cancer Lett. 2017;384:39–49. doi:10.1016/j.canlet.2016.09.020
   PubMed Web of Science ®Google Scholar
• Wang H, Chen B, Shao R, et al. A new prediction model integrated serum lipid profile for patients with multiple myeloma. J Cancer. 2022;13:1796–1807. doi:10.7150/jca.69321
   PubMed Web of Science ®Google Scholar
• Rajkumar SV. Updated diagnostic criteria and staging system for multiple myeloma. Am Soc Clin Oncol Educ Book. 2016;35:e418–e423. doi:10.1200/EDBK_159009.
   PubMedGoogle Scholar
• Manier S, Liu CJ, Avet-Loiseau H, et al. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129:2429–2436. doi:10.1182/blood-2016-09-742296
   PubMed Web of Science ®Google Scholar
• Dolan RD, Laird B, Horgan PG, et al. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review. Crit Rev Oncol Hematol. 2018;132:130–137. doi:10.1016/j.critrevonc.2018.09.016
   PubMed Web of Science ®Google Scholar
• Podar K, Chauhan D, Anderson KC. Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia. 2009;23:10–24. doi:10.1038/leu.2008.259
   PubMed Web of Science ®Google Scholar
• Zhao QT, Yuan Z, Zhang H, et al. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients. Int J Cancer. 2016;139:164–170. doi:10.1002/ijc.30060
   PubMed Web of Science ®Google Scholar
• Xu B, Chen Z, Zhang J, et al. Prognostic value of peripheral whole blood cell counts derived indexes in gallbladder carcinoma: A systematic review and meta-analysis. Front Oncol. 2021;11:707742), doi:10.3389/fonc.2021.707742
   PubMed Web of Science ®Google Scholar
• Mu S, Ai L, Fan F, et al. Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose-response meta-analysis. Cancer Cell Int. 2018;18:119), doi:10.1186/s12935-018-0609-9
   PubMed Web of Science ®Google Scholar
• Podar K, Chauhan D, Anderson KC. Bone marrow microenvironment and the identification of new targets for myeloma therapy. Leukemia. 2009;23:10–24. doi:10.1038/leu.2008.259
   PubMed Web of Science ®Google Scholar
• Chauhan D, Singh AV, Brahmandam M, et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell. 2009;16:309–323. doi:10.1016/j.ccr.2009.08.019
   PubMed Web of Science ®Google Scholar
• Zhang X, Duan J, Wen Z, et al. Are the derived indexes of peripheral whole blood cell counts (NLR, PLR, LMR/MLR) clinically significant prognostic biomarkers in multiple myeloma? A Systematic Review And Meta-Analysis. Front Oncol. 2021;11:766672. doi:10.3389/fonc.2021.766672.
   PubMed Web of Science ®Google Scholar
• Onec B, Okutan H, Albayrak M, et al. The predictive role of the neutrophil/lymphocyte ratio in survival with multiple myeloma: A single center experience. J Clin Lab Anal. 2017;31:e22032. doi:10.1002/jcla.22032.
   PubMed Web of Science ®Google Scholar
• Wongrakpanich S, George G, Chaiwatcharayut W, et al. The prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients With multiple myeloma. J Clin Lab Anal. 2016;30:1208–1213. doi:10.1002/jcla.22004
   PubMed Web of Science ®Google Scholar
• Kelkitli E, Atay H, Cilingir F, et al. Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio. Ann Hematol. 2014;93:841–846. doi:10.1007/s00277-013-1978-8
   PubMed Web of Science ®Google Scholar
• Romano A, Parrinello NL, Consoli ML, et al. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Ann Hematol. 2015;94:1875–1883. doi:10.1007/s00277-015-2462-4
   PubMed Web of Science ®Google Scholar
• Shi L, Qin X, Wang H, et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget. 2017;8:18792–18801. doi:10.18632/oncotarget.13320
   PubMedGoogle Scholar
• Catapano AL, Pirillo A, Bonacina F, et al. HDL in innate and adaptive immunity. Cardiovasc Res. 2014;103:372–383. doi:10.1093/cvr/cvu150
   PubMed Web of Science ®Google Scholar
• Pirro M, Ricciuti B, Rader DJ, et al. High density lipoprotein cholesterol and cancer: marker or causative? Prog Lipid Res. 2018;71:54–69. doi:10.1016/j.plipres.2018.06.001
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328:1689–1693. doi:10.1126/science.1189731
   PubMed Web of Science ®Google Scholar
• Nowak C, Ärnlöv J. A Mendelian randomization study of the effects of blood lipids on breast cancer risk. Nat Commun. 2018;9:3957), doi:10.1038/s41467-018-06467-9
   PubMed Web of Science ®Google Scholar
• Bull CJ, Bonilla C, Holly JM, et al. Blood lipids and prostate cancer: a Mendelian randomization analysis. Cancer Med. 2016;5:1125–1136. doi:10.1002/cam4.695
   PubMed Web of Science ®Google Scholar
• Seth D, Garmo H, Wigertz A, et al. Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study. Int J Mol Epidemiol Genet. 2012;3:122–133. http://www.ijmeg.org/ISSN1989-1975/IJMEG1203002.
   PubMedGoogle Scholar
• Rodriguez-Broadbent H, Law PJ, Sud A, et al. Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer. Int J Cancer. 2017;140:2701–2708. doi:10.1002/ijc.30709
   PubMed Web of Science ®Google Scholar
• Gao M, Zhao D, Schouteden S, et al. Abstract 8: effect of intensive lipid therapy on plaque lipid depletion as assessed by magnetic resonance imaging. Arterioscler Thromb Vasc Biol. 2014;34:1900–1909. doi:10.1161/atvb.34.suppl_1.8
   PubMed Web of Science ®Google Scholar
• Feng Y, Schouteden S, Geenens R, et al. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. Plos One. 2012;7:e47286), doi:10.1371/journal.pone.0047286
   PubMed Web of Science ®Google Scholar
• Ding D, Feng Y, Song B, et al. Effects of preoperative and postoperative enteral nutrition on postoperative nutritional status and immune function of gastric cancer patients. Turk J Gastroenterol. 2015;26:181–185. doi:10.5152/tjg.2015.3993
   PubMed Web of Science ®Google Scholar